Human Islet MicroRNA-200c Is Elevated in Type 2 Diabetes and Targets the Transcription Factor ETV5 to Reduce Insulin Secretion
Authors:
- Jones K. OforiJOJones K. Ofori
- Alexandros KaragiannopoulosAKAlexandros Karagiannopoulos
- Mototsugu NagaoMNMototsugu Nagao
- Efraim WestholmEWEfraim Westholm
- Shaima RamadanSRShaima Ramadan
- Anna WendtAWAnna Wendt
- Jonathan L.S. EsguerraJEJonathan L.S. Esguerra
- Lena EliassonLELena Eliasson
Open Access
- 9 November 2021
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 71 (2) , 275-284
Abstract
MicroRNAs (miRNAs) are part of deregulated insulin secretion in type 2 diabetes (T2D) development. Rodent models have suggested miR-200c to be involved, but the role and potential as therapeutic target of this miRNA in human islets are not clear. Here we report increased expression of miR-200c in islets from T2D as compared with nondiabetic (ND) donors and display results showing reduced glucose-stimulated insulin secretion in EndoC-βH1 cells overexpressing miR-200c. We identify transcription factor ETV5 as the top rank target of miR-200c in human islets using TargetScan in combination with Pearson correlation analysis of miR-200c and mRNA expression data from the same human donors. Among other targets were JAZF1, as earlier shown in miR-200 knockout mice. Accordingly, linear model analysis of ETV5 and JAZF1 gene expression showed reduced expression of both genes in islets from human T2D donors. Western blot analysis confirmed the reduced expression of ETV5 on the protein level in EndoC-βH1 cells overexpressing miR-200c, and luciferase assay validated ETV5 as a direct target of miR-200c. Finally, LNA knockdown of miR-200c increased glucose-stimulated insulin secretion in islets from T2D donors approximately threefold. Our data reveal a vital role of the miR-200c–ETV5 axis in β-cell dysfunction and pathophysiology of T2D.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- MicroRNA Expression in Alpha and Beta Cells of Human Pancreatic IsletsPLOS ONE, 2013
- Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetesMolecular and Cellular Endocrinology, 2012
- A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretionJournal of Clinical Investigation, 2011
- Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesisNature Genetics, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Six new loci associated with body mass index highlight a neuronal influence on body weight regulationNature Genetics, 2008
- Association Testing of Novel Type 2 Diabetes Risk Alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With Insulin Release, Insulin Sensitivity, and Obesity in a Population-Based Sample of 4,516 Glucose-Tolerant Middle-Aged DanesDiabetes, 2008
- Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetesNature Genetics, 2008
- ERM is required for transcriptional control of the spermatogonial stem cell nicheNature, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001